mini-review systematic review of structural and functional
TRANSCRIPT
Mini-Review
Systematic Review of Structural and FunctionalNeuroimaging Findings in Children and Adults withCKD
Divya G. Moodalbail,* Kathryn A. Reiser,* John A. Detre,†‡ Robert T. Schultz,* John D. Herrington,*Christos Davatzikos,‡ Jimit J. Doshi,‡ Guray Erus,‡ Hua-Shan Liu,†‡ Jerilynn Radcliffe,* Susan L. Furth,*§
and Stephen R. Hooper|
SummaryCKD has been linked with cognitive deficits and affective disorders in multiple studies. Analysis of structural andfunctional neuroimaging in adults and childrenwith kidney diseasemay provide additional important insights intothe pathobiology of this relationship. This paper comprehensively reviews neuroimaging studies in both childrenand adults. Major databases (PsychLit, MEDLINE, WorldCat, ArticleFirst, PubMed, Ovid MEDLINE) weresearched using consistent search terms, and studies published between 1975 and 2012 were included if theirsamples focused on CKD as the primary disease process. Exclusion criteria included case reports, chapters, andreview articles. This systematic process yielded 43 studies for inclusion (30 in adults, 13 in children). Findings fromthis review identified several clear trends: (1) presence of cerebral atrophy and cerebral density changes inpatients with CKD; (2) cerebral vascular disease, including deep white matter hyperintensities, white matterlesions, cerebral microbleeds, silent cerebral infarction, and cortical infarction, in patients with CKD; and (3)similarities in regional cerebral blood flow between patients with CKD and those with affective disorders. Thesefindings document the importance of neuroimaging procedures in understanding the effect of CKD on brainstructure, function, and associated behaviors. Results provide a developmental linkage between childhood andadulthood,with respect to the effect of CKDon brain functioning across the lifespan,with strong implications for acerebrovascular mechanism contributing to this developmental linkage. Use of neuroimaging methods to cor-roborate manifest neuropsychological deficits or perhaps to indicate preventive actions may prove useful toindividuals with CKD.
Clin J Am Soc Nephrol 8: 1429–1448, 2013. doi: 10.2215/CJN.11601112
IntroductionKidney function may affect brain function on manylevels, ranging from developmental alterations andvascular injury to disorders of metabolism. There isincreasing interest in understanding the neurologicbasis of cognitive and affective dysfunction in childrenand adults with kidney disease that is evident inneurobehavioral findings across the lifespan (e.g.,increased rates of neurocognitive impairments in chil-dren; increased rates of dementia in adults). Neuro-imaging methods provide a noninvasive means ofexamining brain structure and function (1) and repre-sent an important approach for further elucidating thekidney-brain connection in individuals with CKD.
Sixteen years ago, Butler et al. (2) touted the benefitsof using magnetic resonance angiography as a screen-ing tool for cerebral aneurysms and subarachnoidhemorrhage in patients with autosomal dominantpolycystic kidney disease (ADPKD). Similarly, Burnand Bates (3) reviewed neurologic presentations inpatients with a wide range of kidney diseases (e.g.,Von Hippel-Lindau disease) from genetic predisposi-tion to tumors to direct and indirect effects of kidneydisease on brain functioning.
To date, several comprehensive reviews have ex-amined the neuroimaging literature in individualswith CKD. Aǧildere et al. (4) provided one of the firstreviews of the neurologic complications of ESRD inpatients undergoing hemodialysis (HD) assessed byuse of magnetic resonance imaging (MRI). These in-vestigators highlighted the importance of MRI, in-cluding T2-weighted, fluid-attenuated inversionrecovery, and proton density images, as a tool forclinical investigation of ESRD-associated neurologicsymptoms. They reported that patients with ESRD,particularly those receiving HD, have high rates ofneurologic complications compared with healthy con-trols. They surveyed the use of MRI in combinationwith new and conventional imaging methods fordiagnosing white matter changes, cerebral atrophy,osmotic demyelination syndrome, dialysis encepha-lopathy, hypertensive encephalopathy, intracranialhemorrhage, cerebral ischemia and infarction, infec-tion, and sinus thrombosis.Brouns and De Deyn (5) also reviewed the causes
and presentations of neurologic complications in ure-mic patients with ESRD. They noted that dialysis andrenal transplantation themselves may precipitate
*Department ofPediatrics, TheChildren’s Hospital ofPhiladelphia,Philadelphia,Pennsylvania;†Department ofNeurology,‡Department ofRadiology, and§Department ofEpidemiology,Perelman School ofMedicine at theUniversity ofPennsylvania,Philadelphia,Pennsylvania; and|Department ofPsychiatry andCarolina Institute forDevelopmentalDisabilities,University of NorthCarolina School ofMedicine, ChapelHill, North Carolina
Correspondence:Dr. Divya G.Moodalbail, TheChildren’s Hospital ofPhiladelphia, 34thStreet and CivicCenter Boulevard,Philadelphia, PA19104. Email: [email protected]
www.cjasn.org Vol 8 August, 2013 Copyright © 2013 by the American Society of Nephrology 1429
neurologic symptoms and that treatment and maintenancefor patients with ESRD should address both renal andneurologic components. More recently, Lakadamyali andErgün (6) reviewed brain MRI findings for diagnosis ofacute neurologic complications in patients with ESRD un-dergoing HD. They noted that symptoms may be causeddirectly by CKD itself, HD, or a combination of the two.Cerebral ischemia and infarction, intracerebral hemor-rhage, posterior reversible encephalopathy syndrome, os-motic demyelination syndrome, cerebral infection,gadolinium accumulation, sinus vein thrombosis, and di-alysis disequilibrium syndrome are all reported as beingdetected via MRI. Vogels et al. (7) reviewed the associationbetween CKD and brain lesions as noted on MRI and com-puted tomography (CT). They reported association ofCKD with brain atrophy, silent cerebral infarction, andwhite matter lesions (WMLs).Taken together, these earlier reviews describe the neu-
rologic complications that can stem from CKD. Impor-tantly, however, none of these reviews provide findingspertaining to children. In addition, the earlier reviewsfocused on specific neurologic complications from CKDand did not provide a broad overview of the neuroimagingliterature related to CKD.This paper provides an updated review of neuroimaging
in kidney disease, focusing on quantitative findings fromboth structural and functional neuroimaging studies inchildren and adults. The primary objective is to provide acontemporary summary of the available studies. Analysisof structural and functional neuroimaging in adults andchildren with kidney disease will provide additionalimportant insights into the pathobiology of CKD.
MethodsA systematic review of major search databases was
conducted to compile a comprehensive list of studies thatused neuroimaging techniques in individuals with CKDand were published between 1975 and 2012. Three re-viewers systematically reviewed databases, including Psy-chLit, Ovid MEDLINE, MEDLINE, WorldCat, PubMed,and ArticleFirst. Designated search terms included MRIAND chronic kidney disease, computed tomography AND he-mofiltration, polycystic kidney AND brain AND magnetic res-onance imaging, dialysis AND single-photon emissioncomputed tomography (SPECT), dialysis AND MRI, dialysisAND regional cerebral blood flow (rCBF), rCBF AND CKD,CKD AND CT, dialysis AND transcranial Doppler, dialysisAND cerebral magnetic resonance imaging, neurologic impair-ment in CKD, neuroimaging AND CKD, and diffusion tensorimaging (DTI) AND CKD. Studies were included in the re-view if (1) the sample focused on CKD (defined by an esti-mated GFR [eGFR] ,60 ml/min per 1.73 m2 for$3 months)as the primary disease process and (2) the study producedquantitative statistics. Exclusion criteria included case re-ports, book chapters, and previous review articles.Use of the search terms in this systematic process
produced 1462 possible articles, and an additional 9 re-cords were identified through other sources (e.g., citationsincluded in the ascertained articles). Removal of the dupli-cate articles resulted in a pool of 1264 potential articles forinclusion. Application of the inclusion and exclusion
criteria produced 43 articles for inclusion in the review.These studies comprised 30 studies in adults (20 structural,10 functional) and 13 studies in children (13 structural).The selection and identification process for candidate stud-ies can be seen in Figure 1.
ResultsAdult Neuroimaging StudiesThirty studies included adults with CKD in their neuro-
imaging protocols: 20 structural and 10 functional. Thesestudies span a time frame from 1987 (8) to 2011 (9–11). Thestudy designs included retrospective, cross-sectional, case-control, and prospective approaches to data collection. Sam-ple sizes ranged widely, and the composition of the CKDsamples reflected significant heterogeneity across studies.Other studies examined AKI (e.g., Ronco et al. 12); however,our review focuses on CKD. For the structural neuroimagingstudies, the primary technique used was MRI, with severalstudies using CT. For the functional neuroimaging studies,the primary techniques used were SPECT, transcranialDoppler ultrasonography, and rCBF using 133Xe inhalation.
Findings in Adult Structural Neuroimaging StudiesIn adults, more severe kidney disease has been associ-
ated with abnormal structural findings. One study hasdocumented the presence of intracranial arachnoid cysts inADPKD (13), but more studies examined MRI findings inpatients undergoing various renal replacement therapies(RRTs) and have reported the presence of cerebral atrophyand decreased cerebral density in both white and graymatter (9,14–21). Walters et al. (18) showed that five HDpatients had postdialysis increases in cerebral volumecompared with five controls. Savazzi et al. (20) foundhigh correlations between atrophy on CT and MRI andpredialytic BP. Yoshimitsu et al. (19) also studied MRI inHD patients and reported significantly more lacunae andmore advanced periventricular hyperintensity thanmatched controls. In one of the largest studies conductedto date (187 kidney transplant and 29 liver transplant cases),Aǧildere et al. (16) found that roughly one third of adultrenal transplant recipients had neuroradiologic findings onMRI, including nearly 20% of patients with hemisphericsulcal and ventricular dilatation.Similar findings have been uncovered in patients not
receiving RRT. In neuroimaging studies conducted to date,with sample sizes ranging from 52 to 625 adult cases withCKD, high rates of structural abnormalities were detectedwith MRI, including WMLs (22). In a study by Wada et al.(23), elderly patients with CKD (defined by low eGFR[,60 ml/min per 1.73 m2] or a urinary albumin-to-creati-nine ratio .30 mg/g) evidenced more lacunar infarcts andhigher grades of WMLs. After adjustment for hypertensionand diabetes, CKD continued to remain an independentrisk factor for cerebrovascular disease–related lesions. Sev-eral other investigators have reported similar findings (24–27). Using DTI, Kim et al. (9) showed subtle WMLs in asmall sample of patients receiving peritoneal dialysis (PD).Cerebral small vessel disease has also been studied in the
adult CKD population. Kobayashi et al. (28) found thatdecreased kidney function was a risk factor for silent la-cunar infarcts. The prevalence of silent cerebral infarction
1430 Clinical Journal of the American Society of Nephrology
also has been reported to be significantly higher in HD pa-tients than in controls (17). Kobayashi et al. (29) also foundan independent association between silent cerebral infarc-tion and decreased kidney function, and silent cerebral in-farction independently predicted outcomes, including strokeand dementia. Other investigators have asserted that WMLsreflect possible ischemic brain damage and generalized vas-cular damage, and both are independently associated withvascular nephropathy in patients with CKD (22). In patientswith CKD, high rates of cerebral microbleeds have also beendocumented, with rates ranging from about 26% (30) to 61%(29). These microbleeds tended to be more prevalent in malepatients, those with hypertension, those with advanced age,and those with worsening kidney function as defined byeGFR, with no relation to the use of antiplatelet or anti-thrombotic therapy (15,30,31). Table 1 summarizes the adultstructural neuroimaging studies in CKD.
Findings in Adult Functional Neuroimaging StudiesFunctional neuroimaging studies use methods to detect
structural brain abnormalities and localized neural activity
in reaction to executing certain specific sensory, motor, andcognitive tasks. These studies are sensitive to changes inrCBF and blood flow velocity in targeted brain regions.Seven of the 10 studies included in this review focused onpatients receiving HD or PD. In one of the oldest imagingstudies conducted with adults, which used 133Xe inhala-tion, Gottlieb et al. (8) found that predialysis rCBF valuesdid not differ from those in age-matched controls; how-ever, after HD, there was a mild but significant reductionin rCBF. This reduction was not associated with cognitiveimpairment or neurologic symptoms. Using transcranialDoppler ultrasonography, several studies have docu-mented similar findings. Prohovnik et al. (32) showedthat 19 HD patients had reduced rCBF between sessions.Other investigators have reported similar findings (33,34),with blood flow reductions noted in the middle cerebralartery and the basilar artery after HD (35). However, somestudies report contrary findings, suggesting that cerebralblood flow does not change significantly during or afterHD (36). Many functional neuroimaging studies also haveused SPECT in their examination of blood flow velocities
Figure 1. | Systematic review of neuroimaging data in CKD. *Studies where CKD was not the primary disease process of interest, but otherassociated disease processes (e.g., stroke) were screened for in large populations of patients with CKD. Reproduced with permission fromMoher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: ThePRISMA statement. PLoS Med 6: e1000097, 2009.
Clin J Am Soc Nephrol 8: 1429–1448, August, 2013 Neuroimaging in CKD, Moodalbail et al. 1431
Tab
le1.
Adultstructuralneu
roim
agingstudiesin
CKD
(n=20)
Autho
rsSa
mpleDescription
Stud
yDesign
Imag
ingTechn
ique
MainFind
ings
Nag
anuma
etal.(20
12)
n=17
9HD
patien
ts;m
ean
age,
58.2
yr(ran
ge,2
3–86
yr)
n=58
healthycontrols;m
ean
age,
55.9
yr(ran
ge,4
1–77
)
Cross-section
alMRI(T1-,T
2-weigh
ted
andFL
AIR
)The
prev
alen
ceof
WMHswas
sign
ificantly
high
erin
HD
patien
tsthan
healthype
rson
s.In
theHD
patien
ts,
multiple
logisticregression
analysisshow
edthat
indep
enden
tand
sign
ificant
factorsassociated
withthe
presen
ceof
PVH
wereag
e,femalesex,
andsystolic
BPan
dthoseassociated
withthepresen
ceof
DSW
MH
wereag
e,femalesex,
systolicBP,
andbo
dymassindex.
Kim et
al.(20
11)
n=4pa
tien
tswithESR
Don
PD$
3yr;3
men
and1
wom
an;m
eanag
e,39
.75yr
n=6controls;4
men
and2
wom
en;m
eanag
e,44
.17yr
Cross-section
alDTI
DTIfind
ings
wereinve
stigated
inpa
tien
tswithESR
Dwho
show
edno
specificlesion
son
conv
ention
albrainMRI.
DTItractograp
hyshow
edthat
all4
patien
tsha
d.1
lesion
.PatientswithESR
Dshow
edab
norm
alitieson
DTIthat
wereassociated
withcogn
ition;
howev
er,the
ydid
notsh
owsign
ificant
cogn
itiveab
norm
alities.
Kob
ayashi
etal.(20
10)
n=14
2pa
tien
tswithCKD;
96meanan
d46
wom
en;
meanag
e,64
.7yr
Prospective
coho
rtMRI(T1-,T
2-,
andproton
den
sity–weigh
ted
imag
es)
Atb
aseline,87
patien
tsha
dSB
I.During
2-yr
follo
w-up,
43pa
tien
ts(30.3%
)dev
elop
edthefollo
wingprim
ary
outcom
es:d
oublingof
SCrleve
l,dialysistherap
y,an
ddeath
from
card
iova
scular
caus
es.S
BIwas
anindep
enden
tpredictorof
outcom
es;eGFR
decreased
morein
patien
tswithSB
Ithan
inthosewitho
utS
BI.
Shim
aetal.(20
10)
n=16
2pa
tien
tswithCKD,
stag
es1–
5;85
withdiabe
tes,
77witho
utd
iabe
tes;92
men
and70
wom
en;m
eanag
e,64
.9yr
n=24
controls;1
4men
and10
wom
en;
meanag
e,59
.7yr
Cross-section
alMRI(T1-,T
2-,F
LAIR
,an
dT2*-w
eigh
ted
imag
es)
CMBswerefoun
din
35pa
tien
tswithCKD
(25.6%
)but
notincontrols.C
MBsweremoreprev
alen
tin
men
,thosewithhigh
erBP,tho
sewithad
vanc
edag
e,an
dthosewithpo
orkidne
yfunc
tion
.The
rewas
anassociationbe
tweentheprev
alen
ceof
CMBsan
dad
vanc
ingCKD
stag
e(P,0.01
).eG
FRwas
associated
withtheprev
alen
ceof
CMBsindep
enden
tofa
ge,
sex,
andhy
perten
sion
;how
ever,n
orelation
ship
was
seen
betw
eenCMBsan
ddiabe
tesmellitus
anddyslip
idem
ia.
Yak
ushiji
etal.(20
10)
n=61
0Japan
esead
ultswith
CKD;3
02men
and30
8wom
en;m
eanag
e,56
.4yr
Cross-section
alMRI(T1-,T
2-,a
ndFL
AIR
weigh
ted
imag
es)
Cereb
rala
trop
hywas
foun
din
25(4.1%)cases.Age
,male
sex,
hypertens
ion,
kidne
yfunc
tion
,WMH,a
ndlacu
naewereassociated
withcerebral
atroph
y.eG
FR,
60ml/min
per1.73
m2was
associated
withcerebral
atroph
y.Treatmen
tofC
KD
may
controla
ge-related
deg
enerativeprocesses
ofthebrain.
Kob
ayashi
etal.(20
09)
n=33
5pa
tien
tswithCKD
n=40
patien
tswithEHTan
dno
CKD;n
otag
e-match
edOve
rall:
226men
and14
9wom
en;m
eanag
e,63
.5yr
Cross-section
alMRI(T1-,T
2-,
andproton
den
sity–weigh
ted
imag
es)
SBIs
wereseen
56.5%
ofpa
tien
ts.H
ypertens
ive
neph
rosclerosisan
dad
vanc
ingeG
FRstatewere
associated
withSB
I.eG
FRwas
relatedto
SBI,in
additionto
agean
dBP(P=0.02
5).
Patien
tswithCKD
shou
ldun
dergo
active
detection
ofSB
Ian
dmoreintens
iveprev
entive
man
agem
ent,especially
forhy
perten
sion
.
1432 Clinical Journal of the American Society of Nephrology
Tab
le1.(Continued
)
Autho
rsSa
mpleDescription
Stud
yDesign
Imag
ingTechn
ique
MainFind
ings
Ikram
etal.(20
08)
n=48
4pa
tien
tsin
theRotterd
amStudy;
meaneG
FR,
54.8
ml/min
per1.73
m2 ;23
9men
and24
5wom
en;m
ean
age,
73.4
yr
Cross-section
alMRI(T1-,T
2-an
dproton
den
sity–weigh
ted
imag
es)
Volum
esof
WMLan
dpresen
ceof
lacu
narinfarcts
reflected
cerebral
smallv
esseld
isease.P
ersons
withlower
GFR
had
less
deepwhite
mattervo
lumean
dW
ML.G
FRwas
not
associated
withgray
mattervo
lumeor
loba
rwhite
mattervo
lume.
Impa
ired
kidne
yfunc
tion
was
associated
withcerebral
smallv
esseld
isease.
Wad
aetal.(20
08)
n=62
5community-based
Japan
eseelderly;3
59men
and26
6wom
en;m
ean
age,
62.7
yr
Cross-section
alMRI(T1-,T
2-,a
ndFL
AIR
-weigh
ted
imag
es)
Patien
tswithlower
eGFR
show
edmorelacu
narinfarcts
andhigh
ergrad
esof
WML.T
hemeangrad
esof
WML
orthemeannu
mbe
rsof
lacu
narinfarction
inthe
patien
tswithalbu
minuriaweregreaterthan
thosein
patien
tswitho
utalbu
minuria.A
fter
exclusion
ofpa
tien
tswithstag
e2hy
pertens
ionor
diabe
tes,CKD
remaine
dan
indep
enden
triskforCVD-related
lesion
s.Kha
tri
etal.(20
07)
n=61
5pa
tien
tswithCKD
from
NorthernMan
hattan
Stud
y;24
6men
and36
9wom
en;
meanag
e,70
yr
Cross-section
alMRI(FLAIR
imag
es)
Creatinineclearanc
e15
–60
ml/min
was
associated
with
increasedlog-white
matterhy
perintensityvo
lumeas
was
eGFR
15–60
ml/min.F
indings
high
light
the
impo
rtan
ceof
CKD
asapo
ssible
determinan
tof
cerebrov
ascu
lardisease
and/or
asamarke
rof
microan
giop
athy
.Kim et
al.(20
07)
n=57
PDpa
tien
ts;3
4men
and
23wom
en;m
eanag
e,48
.4yr
n=57
match
edhy
perten
sive
controlswithno
rmal
rena
lfunc
tion
;34men
and23
wom
en;m
eanag
e,51
.9yr
Cross-section
alMRI(T1-,T
2-,a
ndFL
AIR
-weigh
ted
imag
es)
The
prev
alen
ceof
leuko
araiosiswas
sign
ificantly
greater
inpa
tien
tson
PDthan
controls(P,0.00
1).H
ighe
rT2sign
alintens
itieswereseen
inthePD
patien
tsthan
incontrols,p
articu
larlyin
thean
terior
circulationof
thebrainwithrelative
sparingof
thepo
steriorfossa.
ESR
D,o
lder
age,
andpo
orcontrolo
fBPweresign
ificant
pred
ictors
ofleuk
oaraiosis.
Watan
abe
(200
7)n=
80HD
patien
ts;3
4men
and
46wom
en;m
eanag
e,62
.9yr
Cross-section
alMRI(T2-weigh
ted
imag
es)
CMBswerefoun
din
28pa
tien
ts(35%
).The
duration
ofHD
did
notsign
ificantly
affect
theap
pearan
ceof
theCMBs.
Old
intracereb
ralh
emorrhag
eswereseen
in7pa
tien
ts,
5of
who
m(71%
)had
CMBs.The
freq
uenc
yof
old
intracereb
ralh
emorrhag
eswas
sign
ificantly
high
erin
thepa
tien
tswithCMBsthan
inthosewitho
utC
MBs
(P=0.48
),an
dthepa
tien
tswitholdintracereb
ral
hemorrhag
esha
dsign
ificantly
moreCMBsthan
the
patien
tswitho
utthem
(P=0.00
65).The
high
ratioof
patien
tswithCMBswas
considered
toha
vebe
encaused
notb
ymainten
ance
HD
butby
othe
rfactors,su
chas
hype
rten
sion
.
Clin J Am Soc Nephrol 8: 1429–1448, August, 2013 Neuroimaging in CKD, Moodalbail et al. 1433
Tab
le1.(Continued
)
Autho
rsSa
mpleDescription
Stud
yDesign
Imag
ingTechn
ique
MainFind
ings
Aǧildere
etal.(20
06)
n=18
7kidne
ytran
splant
cases;
ofcaseswithne
urorad
iologic
find
ings;3
6men
and20
wom
en;m
eanag
e,39
.3yr
n=29
liver
tran
splant
cases;22
men
and7wom
en;m
ean
age,
29.4
yr
Retrosp
ective
MRI(T-2
weigh
ted
andproton
den
sity–or
FLAIR
-and
T1-weigh
ted
sequ
ences)
Neu
roradiologicfind
ings
wereclassified
into
3grou
ps:
Group
1was
relatedto
tran
splantation.
Ove
rall,
30%
ofkidne
ytran
splant
recipientsha
dne
uroradiologic
find
ings:3
patien
ts(1.6%)h
adpo
steriorreve
rsible
encepha
lopa
thysynd
rome;2pa
tien
ts(1.1%)h
adtube
rculosisgran
ulom
as;1
patien
t(0.5%
)had
osmotic
dem
yelin
ationsynd
rome;1pa
tien
t(0.5%
)had
aNocardiaab
scess;an
d1(0.5%)h
adfocalcereb
ritis.
Group
2was
relatedto
chronicpa
renc
hymal
disease.
Includingkidne
yan
dliv
ertran
splant
recipien
ts,
38pa
tien
ts(20.3%
)had
brainatroph
y;37
(20%
),white
matterch
ange
s;3(1.6%),sinu
sthrombo
sis;
8(4.3%),lacu
narinfarct;1(0.5%),rena
losteod
ystrop
hyin
thecran
ialb
ones;a
nd4(2.2%),
intracranial
hemorrhag
esecond
aryto
ESR
D.
Group
3was
relatedto
neithe
rtran
splant
norch
ronic
parenc
hymal
disease:3
patien
ts(1.6%)h
adintracranial
lipom
as;1
(0.5%),mesialtem
poralsclerosis;a
nd1
(0.5%),an
anterior
white
matteran
eurysm
inrena
ltran
splant
patien
ts.
Martine
z-Vea
etal.(20
06)
n=52
patien
tswithCKD
stag
es3an
d4witho
utdiabe
tes;
SCr,2.03
–7.91
mg/
dl;38
men
and14
wom
en;m
ean
age,
49yr
n=32
controls;2
1men
and11
wom
en;m
eanag
e,49
yr
Cross-section
alMRI(T1-,T
2-,a
ndFL
AIR
-weigh
ted
imag
es)
WMLweremoreprev
alen
tintheCKD
grou
pthan
incontrols(33%
versus6%
;P=0.00
8).W
MLweremore
common
inpa
tien
tswho
wereolder;h
adrena
ldisease
causedby
card
iova
scular
disease
orva
scular
neph
ropathy
;and
hadhigh
ersystolicBP,
greater
pulsepressu
re,large
rleftve
ntricu
larmassindex,
greaterleve
lsof
C-reactiveprotein,
andhigh
errates
ofan
tihy
perten
sive
drugprescription
s.Stag
ean
dduration
ofCKD
wereno
trelated
tothepresen
ceof
WML.O
nlyva
scular
neph
ropathy
(P=0.03
)pred
ictedan
increasedrisk
forW
ML,sug
gesting
that
WMLreflectische
micbraindam
agecaused
byge
neraliz
edva
scular
dam
age.
1434 Clinical Journal of the American Society of Nephrology
Tab
le1.(Continued
)
Autho
rsSa
mpleDescription
Stud
yDesign
Imag
ingTechn
ique
MainFind
ings
Kob
ayashi
etal.(20
04)
n=51
patien
tswithCKD;m
ean
SCr,2.01
mg/
dl;29
men
and
22wom
en;m
eanag
e,52
.7yr
n=80
controlp
atientswith
EHTbu
tno
CKD;4
7men
and
33wom
en;m
eanag
e,58
.8yr
Cross-section
alMRI
Lacun
aeprev
alen
cewas
25%
inpa
tien
tswithaCcr
.40
ml/min
per1.73
m2 ,85
%in
patien
tswithaCcr
,40
ml/min
per1.73
m2 ,an
d29
%in
patien
tswithessential
hype
rten
sion
withno
rmal
rena
lfunc
tion
.Patientswith
lacu
naeha
dsign
ificantly
lower
hematocrits
associated
withincreasedfibrinog
enan
dlip
oprotein
leve
lscompa
redwiththosewitho
utlacun
ae.P
lasm
atotal
homocysteinean
dinsu
linleve
lsat
2hr
aftera
75-g
gluc
osetoleranc
etest
correlated
withlacu
nae.
Isch
emic
heartc
hang
eson
echo
card
iograp
hyan
dthicke
nedcarotidintima-med
iathickn
essweremore
freq
uent
inpa
tien
tswithlacu
nae.The
best
contribu
ting
factor
forlacu
narinfarcts
was
declin
ein
Ccr.D
ecreased
rena
lfunc
tion
isarisk
factor
forsilent
lacu
narinfarcts.
Nak
atan
ietal.(20
03)
n=12
3HD
patien
ts;8
0men
and
43wom
en;m
eanag
e,55
.6yr
n=52
healthycontrols;2
9men
and23
wom
en;m
ean
age,
51.7
yr
Cross-section
alMRI(T1-,T
2-,
andproton
den
sity–weigh
ted
imag
es)
The
prev
alen
ceof
SCIwas
sign
ificantly
high
erin
HD
patien
tsthan
inhe
althycontrols(P,0.00
01).Fo
rbo
thgrou
ps,indep
enden
triskfactorsforSC
Iwerech
ronic
rena
lfailure,h
ypertens
ion,
smok
ing,
andag
e.In
the
HD
grou
p,a
gean
dsm
okingwereindep
enden
trisk
factorsof
SCI(P,0.00
01),whe
reas
HD
duration
and
hype
rten
sion
wereno
t.The
find
ings
indicatethat
chronicrena
lfailure
maintaine
dby
HD
increasesthe
prev
alen
ceof
SCIan
dthat
agean
dsm
okingarerelated
toSC
Iin
HD
patien
ts.
Walters
etal.(20
01)
n=5HD
patien
ts;3
men
and2
wom
en;m
eanag
e,44
.2yr
n=5he
althycontrols;2
men
and3wom
en;m
eanag
e,67
.4yr
Cross-section
alMRI(T1-weigh
ted
imag
es)
Potentialcereb
ralv
olum
ech
ange
causedby
HD
was
quan
tified
byMRIim
med
iately
before
and
afterHD.P
atientsha
dan
increase
incerebral
volume
afterHD,w
hich
averag
ed32
.8ml(SE
M,7
.4ml).
Con
trolsav
erag
ed1.4ml(SE
M,0
.6ml).N
opa
tien
tha
dsign
ificant
neurolog
icsymptom
s.Yoshimitsu
etal.(20
00)
n=55
HD
patien
ts;3
5men
and
20wom
en;m
eanag
e,52
yrn=
35controls;1
8men
and17
wom
en;m
eanag
e,42
yr
Cross-section
alMRI
HD
patien
tsshow
edmorelacu
naean
dmoread
vanc
edPV
Hthan
controls.T
heVBR,the
numbe
rof
lacu
nae,
andtheseve
rity
ofPV
Htend
edto
increase
with
agein
HD.V
BRsat
alla
gegrou
psweresign
ificantly
high
erin
HD
recipientsthan
incontrols(7.0%
versus3.7%
atthefourth
decad
eof
life;8.4%
versus5.9%
atthefifthdecad
e;9.6%
versus
5.4%
atthesixthdecad
e;an
d11
.6%
versus
6.3%
attheseve
nthdecad
e).B
oththenu
mbe
rof
lacu
naean
dtheseve
rity
ofPV
Hweresign
ificantly
correlated
toVBRin
HD
recipien
ts.
Clin J Am Soc Nephrol 8: 1429–1448, August, 2013 Neuroimaging in CKD, Moodalbail et al. 1435
Tab
le1.(Continued
)
Autho
rsSa
mpleDescription
Stud
yDesign
Imag
ingTechn
ique
MainFind
ings
Sava
zzi
etal.(19
99)
n=25
regu
larHD
treatm
ent
patien
ts;1
9men
and6wom
en;
meanag
e,50
.3yr
Retrosp
ective
CT(n=25
)and
MRI(n=
17)
Nosign
ificant
correlationwas
found
betw
eenthedeg
ree
ofatrophy
andtheurem
ia-altered
labo
ratory
measu
resof
creatinine
,hem
atocrit,ch
olesterol,
triglyceride,albu
min,P
TH,calcium
,and
inorga
nic
phospha
te.N
orelation
ship
betw
eendeg
reeof
atrophy
andnu
mbe
rof
mon
thsthepa
tien
tsha
dbe
enon
HD
ortimethat
passed
betw
eenthe
find
ingof
Ccr
,30
ml/min
per1.73
m2an
dthestart
ofHD.L
arge
correlations
werefound
betw
een
CA
andpred
ialyticBPan
dbe
tweenCA
andthe
duration
ofhy
perten
sion
.Hyp
ertens
ionseem
sto
berelatedto
cerebral
parenc
hymal
dam
agean
dsh
ould
becorrected.
Fazeka
setal.(19
95)
n=30
patien
tswithCHD;2
1men
and9wom
en;m
ean
age,
58yr
n=30
controlsmatch
edfor
age,
sex,
andmajor
cerebrov
ascu
larrisk
factors;
23men
and7wom
en;
meanag
e,60
yr
Cross-section
alMRI(T1-
and
T2-weigh
ted
andax
ial
mixed
-inten
sity
imag
es)
The
brains
ofpa
tien
tswithCHD
show
edsign
ificantly
moreatrophy
onvisu
alrating
andsemiqua
ntitative
morph
ometricmeasu
res.Multiple
lacu
nesor
confl
uent
white
matterhy
perinten
sities
pred
ominated
in33
%of
patien
ts.M
arke
dcogn
itiveim
pairmen
twas
associated
withmoreextens
iveen
largem
ento
fthe
thirdve
ntricle
(P,0.04
)and
thetempo
ralh
orns
(P,0.02
)bu
tno
twiththepresen
ceof
cerebral
isch
emiclesion
sor
any
differenc
ein
labo
ratory
data.
The
seresu
ltscall
attentionto
ave
ryhigh
rate
ofcerebral
dam
agein
individua
lsun
dergo
ingCHD
andsu
ggestbrain
deg
enerationof
toxic-metab
oliccause
that
isassociated
withseve
recogn
itiveim
pairmen
t.Schiev
ink
etal.(19
95)
n=24
7pa
tien
tswithADPKD;
96men
and15
1wom
en;
meanag
e,44
yrn=
247controlsmatch
edfor
agean
dsex
Retrosp
ective
MRI(180
cases)
orCT(67cases)
Une
xpectedly
high
numbe
rof
patien
tswithADPK
Dha
dintracranial
arachn
oidcysts.The
cystswerefoun
din
20pa
tien
ts(8.1%)v
ersu
s2controls
(0.8%)(P,0.00
01).Multiple
intracranial
arachn
oid
cystswerefoun
din
2pa
tien
ts.P
inealcysts
werefoun
din
2pa
tien
ts(0.8%)a
ndch
oroidplexuscy
stswere
foun
din
3pa
tien
ts(1.2%),bu
tthiswas
notdifferent
from
controls.N
oneof
theintracranial
cystswere
symptom
aticor
treatedsu
rgically.
HD,h
emod
ialysis:MRI,mag
neticresona
nceim
aging;
FLAIR,fl
uid-atten
uated
inve
rsionrecove
ry;W
MH,w
hite
matterhy
perinten
sities;P
VH,p
eriven
tricular
hype
rinten
sity;D
SWMH,d
eep
andsu
bcorticalw
hite
matterhy
perinten
sity;P
D,p
eriton
eald
ialysis;DTI,diffusion
-ten
sorim
aging;
SBI,silent
braininfarct;eG
FR,estim
ated
GFR
;CMB,cereb
ralm
icrobleeds;EHT,essen
tial
hype
rten
sion
;WML,w
hite
matterlesion
s;HD,h
emod
ialysis;SC
r,serum
creatinine
;Ccr,creatinineclearanc
e;SC
I,silent
cerebral
infarct;VBR,v
entricular-brain
ratio;
CT,com
putedto-
mog
raph
y;PT
H,p
arathy
roid
horm
one;CA,cereb
rala
trop
hy;C
HD,coron
aryhe
artd
isease;A
DPK
D,a
utosom
aldom
inan
tpolyc
ystickidne
ydisease.
1436 Clinical Journal of the American Society of Nephrology
Tab
le2.
Adultfunctional
neu
roim
agingstudiesin
CKD
(n=10)
Authors
SampleDescription
StudyDesign
Imag
ingTechn
ique
MainFind
ings
Nam
etal.(20
11)
n=14
patien
tswithstag
e5
CKD,eGFR
,15
ml/min
per
1.73
m2or
perm
anen
tren
alreplacemen
tthe
rapy;
10men
and4wom
en;m
eanag
e,54
yr
Prospe
ctive
99mTcECD
SPECT
HDRSan
dSP
ECTweread
ministered
before
starting
dialysisan
d6moafter
dialysisinitiation
.rCBFwas
compa
red
betw
eenpa
tien
tswho
seHDRSscore
decreased
by.25
%an
dthosewho
seHDRSscores
decreased
by,25
%or
thosewithan
increase
inHDRSscore.
Adecreaseof
.25
%in
HDRSwas
correlated
withhigh
erpe
rfusion
inthe
leftmiddle
tempo
ralg
yrus(P=0.05
)an
dhigh
errC
BFin
therigh
tpa
rahipp
ocam
palg
yrus
(P=0.04
).Less
reduc
tion
inHDRSwas
correlated
with
decreased
rCBFin
theleftsu
perior
fron
talg
yrus
(P=0.03
)and
righ
torbitofron
talcortex(P=0.05
).Trycetal.(20
11)
n=23
nond
ialyzedpa
tien
tswith
CKD
stag
es4an
d5;
15men
and
8wom
en;m
eanag
e,48
.4yr
n=15
dialyzedpa
tien
ts;1
0men
and5wom
en;m
eanag
e,52
.5yr
n=23
match
edhe
althycontrols;
9men
and14
wom
en;
meanag
e,52
.5yr
Cross-section
al1 H
-MRS
MRSalteration
swerepred
ominan
tly
foun
din
thewhite
matter.Con
centration
sof
creatinine
-con
tainingcompo
und
sweredecreased
indialyzedan
dno
ndialyzedpa
tien
ts.C
holin
econc
entration
(and
combine
dN-acetylasp
artate
and
N-acetylasp
artylglutamateconc
entration)
werereduc
edin
dialyzedpa
tien
ts.
Disturban
cein
mem
ory/
learning
and
attentionwereob
served
inbo
thpa
tien
tgroup
s,bu
tattentiondefi
cits
weremoreseve
rein
dialyzedpa
tien
ts.
Patien
tswithCKD
witho
utclinical
sign
sof
urem
icen
ceph
alop
athy
show
edmetab
olicdisturban
cesin
distinc
tbrain
region
san
dcogn
itive
impa
irmen
ts.H
Dwas
accompan
ied
bymoreseve
recogn
itivedysfunc
tion
andmetab
olic
alteration
sthan
CKD
alon
e.A
nega
tive
effect
ofHD
oncogn
itivefunc
tion
mus
tbecons
idered
.
Clin J Am Soc Nephrol 8: 1429–1448, August, 2013 Neuroimaging in CKD, Moodalbail et al. 1437
Tab
le2.(Continued
)
Authors
SampleDescription
StudyDesign
Imag
ingTechn
ique
MainFind
ings
Kim
etal.(20
08)
n=27
patien
tswithCKD,
pred
ialyticstag
e4–
5;mean
GFR
,9.1
ml/min
per1.73
m2 ;
16men
and11
wom
en;
meanag
e,51
.9yr
Prospe
ctive
Tc-99
ECD
SPECT
rCBFan
ddep
ressivemoo
dwerene
gative
lycorrelated
intherigh
tins
ula,
posterior
cing
ulated
gyrus,an
dleftsu
perior
tempo
ral
gyrusan
dpo
sitive
lycorrelated
intheleft
fusiform
gyrus.rC
BFan
dinsomniawere
nega
tive
lycorrelated
intherigh
tmiddle
fron
talg
yrus
,bila
teralcingu
latedgy
ri,right
insu
la,right
putamen
,and
righ
tinferior
parietal
lobu
lean
dpo
sitive
lycorrelated
inleftfusiform
gyrusan
dbilateralcereb
ellar
tonsils.rCBFan
dan
xietywerene
gative
lycorrelated
intheleftinferior
fron
talg
yrus
,righ
tsupe
rior
fron
talg
yrus
,right
middle
tempo
ralg
yrus,righ
tsupe
rior
tempo
ralg
yrus
,an
dleftsu
perior
fron
talg
yrus
andpo
sitive
lycorrelated
intherigh
tlingu
algy
rusan
drigh
tpa
rahipp
ocam
palg
yrus
.The
patterns
were
simila
rto
thosewithMD
witho
utCKD.
Proh
ovniketal.(20
07)
n=19
HD
patien
ts;a
llmen
;meanag
e,63
yrn=
5PD
patien
ts;a
llmen
;meanag
e,63
yrn=
14controls;1
1men
and
3wom
en;m
eanag
e,61
yr
Prospe
ctive
MP-RAGE,A
SL,a
ndT1-MRIsequ
ences
plus
ICA
Dop
pler
ultrason
ograph
yan
dcerebral
oxim
etry
HD
patien
tsshow
edbilateralcereb
ralatrop
hyin
thecaudatenu
cleu
san
dmidbrainassociated
withlong
erdurationof
dialysis.Cereb
ral
oxyg
enationan
dcarotidbloo
dflow
werelow
before
dialysiscompa
redwith
controls.C
erebral
oxyg
enationim
prov
edon
lyslightly
afterHD,w
hile
carotid
bloo
dflow
norm
alized
.PD
patientsshow
edva
lues
betw
eenthoseof
HD
patientsan
dcontrols.
Durationof
HDwas
associated
with
glob
algray
mattervo
lume,chan
geof
bloo
dflow
during
dialysis,and
baselin
erSO
2.HD
patientsap
pear
toha
velow
CBF
betw
eensessions.
Skinne
retal.(20
05)
n=12
HD
patien
ts;6
men
and
6wom
en;m
eanag
e,44
yrCase-control
Transcran
ialD
oppler
ultrason
ograph
yMCA
FV,d
ynam
icpressu
reau
toregu
lation
,an
dCRCO
2weremeasu
redbe
fore
andafter
HD.M
CA
FVdecreased
from
57cm
zs21
before
to46
cmzs
21afterHD
(P,0.01
).The
THRRwas
1.29
(0.13)
before
HD
anddid
notch
ange
sign
ificantly
afterHD.C
RCO
2was
21.7
kPa2
1be
fore
HD
andremaine
dun
chan
gedafterw
ard(20.9kP
a21 ).M
CA
FVdecreased
sign
ificantly
afterHD.D
ynam
icpressu
reau
toregu
lation
andCRCO
2remain
norm
alin
patien
tswithCRFan
dareno
talteredsign
ificantly
byHD.
1438 Clinical Journal of the American Society of Nephrology
Tab
le2.(Continued
)
Authors
SampleDescription
StudyDesign
Imag
ingTechn
ique
MainFind
ings
Steafnidisetal.(20
05)
n=18
HD
patien
ts;1
0men
and
8wom
en;m
eanag
e,62
yrCross-section
alTranscran
ialD
oppler
ultrason
ograph
yBeforeHD,the
MFV
intheMCA
was
within
norm
alrang
ean
ddep
enden
tonpa
tien
t’s
age,
butduring
HD
itdecreased
sign
ificantly.T
hisdecreasein
MFV
was
relatedto
ultrafi
ltration
volume,bloo
dvo
lume,an
dpe
rcen
tcha
ngeof
the
hematocritof
thearterial
bloo
dox
ygen
conten
tand
oftheplasmafibrinog
enleve
ls.
The
MFV
intheMCA
decreased
continuou
slyduring
HD.
Metry
etal.(20
02)
n=18
HD
patien
ts;1
3men
and
5wom
en;a
gerang
e,46
–82
yrCross-section
alTranscran
ialD
oppler
ultrason
ograph
yThe
effect
ofhe
mod
ynam
ican
drheo
logic
chan
geson
MFV
was
exam
ined
during
HD
through
continuo
uson
linemon
itoring.
After
HD,h
ematocrita
ndbloo
dan
dplasma
viscosityincreasedsign
ificantly.T
hech
ange
inMFV
was
notsign
ificantly
different
from
zero
andcorrelated
sign
ificantly
withch
ange
inhe
matocrit.
During
HD,the
meanarterial
pressu
rein
15pa
tien
tsmov
edinto
theno
rmal
rang
e,whe
reas
3pa
tien
tsdev
elop
edhy
potens
ion
andtheirMAPdecreased
.Cha
ngein
MFV
was
notsign
ificant.C
BFdoe
sno
tap
pear
tobe
dim
inishe
dsign
ificantly
during
HD.
Lassetal.(19
99)
n=17
patien
tswithESR
Dor
undergo
ingdialysis;13
men
and4wom
en;m
eanag
e,60
yr
Prospe
ctive
Tc-99
HMPA
OSP
ECT
Reg
iona
lcereb
ralp
erfusion
imag
ingwas
performed
,and
activity
inthefron
tala
ndtempo
rallob
eswas
compa
redby
quan
tification
agains
tthe
ipsilaterala
ndcontralateralcereb
ellum
using
three-dim
ension
alsu
rfacemap
ping
.Discretecortical
defects
consistent
with
infarcts
wereseen
in14
patien
ts(82%
).The
defects
werefound
inalllob
ules.T
hemean
righ
tand
leftfron
tal-to-cereb
ellarratios
wereno
tsign
ificantly
different
from
therigh
tan
dlefttempo
ral-to-cereb
ellarratios,a
ndbo
thwerewithinno
rmally
accepted
rang
es,
sugg
esting
noev
iden
ceof
Alzhe
imer-typ
edem
entia.
Clin J Am Soc Nephrol 8: 1429–1448, August, 2013 Neuroimaging in CKD, Moodalbail et al. 1439
Tab
le2.(Continued
)
Authors
SampleDescription
StudyDesign
Imag
ingTechn
ique
MainFind
ings
Hataetal.(19
94)
n=27
HD
patien
ts;1
3men
and
14wom
en;m
eanag
e,52
.4yr
Case-control
Transcran
ial
Dop
pler
ultrason
ograph
y
Blood
FVswereob
tained
from
theMCA
and
theba
silarartery
immed
iately
before
and
afterHD.T
here
was
asign
ificant
reduc
tion
intheMFV
intheMCA
(P,0.01
)an
dthe
basilarartery
(P,0.01
)after
HD.A
nega
tive
correlationwas
observed
betw
eenthe
relative
chan
gein
MFV
andtheloss
ofweigh
tafter
HD,the
amou
ntof
fluid
remov
ed,a
ndtheincrease
inhe
matocritin
themiddle
cerebral
artery
andtheba
silar
artery.H
Dan
dtheassociated
physiologic
chan
gescansign
ificantly
affect
cerebral
circulation
.Trans
cran
ialD
oppler
ultrason
ograph
ycaneffectivelymon
itor
rapid
chan
gesin
thecerebral
circulation
during
HD.
Gottliebetal.(19
87)
n=9pa
tien
tsun
dergo
ing
long
-term
HD;4
men
and
5wom
en;m
eanag
e,50
yrn=
44men
tally
and
neurologically
healthy
controls;a
gerang
e,49
–79
yr
Cross-section
al13
3 Xeinha
lation
tech
niqu
eto
measu
rerC
BF
rCBFwas
measu
redbe
fore
andafterHD.
Pred
ialysisrC
BFva
lues
did
notdiffer
from
thosein
controls.A
fter
HD,rCBF
decreased
byameanof
7%(P=0.02
).Po
st-H
DrC
BFreduc
tion
was
notassociated
withne
urolog
icor
cogn
itivedysfunc
tion
.Cau
sesof
HD-ind
uced
rCBFdecreases
are
unkn
own,
butincreasedbloo
dviscosity
andbioche
mical
chan
ges(e.g.,urea
reduc
tion
,blood
alka
linization)
aresu
spected.
eGFR
,estim
ated
GFR
;ECD,ethylcy
steina
tedim
mer;S
PECT,single-ph
oton
emission
compu
tedtomog
raphy
;HDRS,
Ham
ilton
Dep
ressionRatingScale;rC
BF,
region
alcerebral
bloo
dflow
;MRS,mag
neticresona
ncesp
ectroscopy
;HD,h
emod
ialysis;MD,m
ajor
dep
ression;
PD,p
eriton
eald
ialysis;MP-RAGE,m
agne
tiza
tion
prep
ared
rapid
grad
ient
echo
;ASL
,arterialspinlabe
ling;
MRI,mag
neticresona
nceim
aging;
ICA,interna
lcarotid
artery;rSO
2,region
alox
ygen
saturation
;MCA,m
iddle
cerebral
artery;F
V,fl
owve
locity;C
RCO
2,carbon
dioxidereactivity;T
HRR,
tran
sien
thyp
erem
icresp
onse
ratio;
MFV
,meanflow
velocity;H
MPA
O,h
exam
ethy
lpropylen
eamineox
ime.
1440 Clinical Journal of the American Society of Nephrology
Tab
le3.
Ped
iatric
structuralneu
roim
agingstudiesin
CKD
(n=13)
Authors
SampleDescription
StudyDesign
Imag
ing
Techn
ique
Used
MainFind
ings
Ishiku
raetal.(20
06)
n=20
rena
lpatients;13
boys
and7girls;meanag
e,8.7yr
n=10
kidne
ytran
splant
patien
ts(7
withidiopathic
neph
riticsynd
rome,2with
acute
poststreptococcalG
N,
1withdiffuse
mesan
gial
sclerosis)
Retrosp
ective
coho
rtstud
yCTan
dMRI
Inmostp
atients,radiologicab
norm
alities
extend
edto
thegray
matter(17of
20pa
tien
ts),
fron
tala
ndtempo
rallob
es,a
ndthecerebe
llum
(16pa
tien
ts).Po
steriorreve
rsible
encepha
lopa
thy
synd
romeshou
ldbe
susp
ectedin
pediatric
kidne
ytran
splant
recipien
tsan
dpa
tien
tswithkidne
ydisease
ifthey
have
asu
dden
episod
eof
neurolog
icsymptom
s,ev
enifim
agingfind
ings
areno
trestricted
tothesubcortical
white
matterof
theoccipitalregion.
Valan
neetal.(20
04)
n=33
rena
ltrans
plan
trecipients
who
received
arena
lallo
graft
before
age5yr;2
2bo
ysan
d11
girls;ag
erang
e,6–
11yr
Cross-section
alstud
yCTan
dMRI
Brain
MRIwas
performed
aftertran
splantation.
Pretrans
plan
tCTscan
sof
26pa
tien
tswere
availableforcompa
rison;
18pa
tien
ts(54%
)ha
disch
emiclesion
sin
theva
scular
border
zone
s.Mild
lesion
swereseen
in10
patien
ts,
mod
eratein
6,an
dseve
rein
2.Other
find
ings
wererare.B
rain
lesion
sof
thepa
tien
tsdid
not
correlatewithun
derlyingdisease
butwere
relatedto
adverseclinical
even
tsbefore
tran
splant.
Qvist
etal.(20
02)
n=33
scho
ol-age
child
renwho
received
rena
ltrans
plan
tfor
ESR
Dwhe
nag
e,5yr;2
2bo
ysan
d11
girls;7ch
ildren
attend
ingsp
ecialsch
ool,6
received
remed
ialins
truction,
20in
regu
larinstruction
Prospective
stud
yPretrans
plan
tCT;
post-trans
plant
MRI
Prev
alen
ceof
cerebral
atrophy
aftertran
splant
was
15%;5
5%of
sampleha
dwatersh
edisch
emiclesion
s(5
ofthe7in
specialsch
ool,
5of
6in
remed
ialteach
ing,
8of
20receiving
regu
larinstruction).B
rain
infarcts
wereseen
in6of
7ch
ildrenwho
wereattend
ingsp
ecial
scho
ol.C
hildrenattend
ingsp
ecialsch
oolh
adahigh
errate
ofprem
aturity,h
ypertens
ive
crises
(P=0.00
2),a
ndseizures(P=0.03
),with
man
yof
theseev
ents
occu
rringduring
dialysis.
Elzou
iki(19
94)
n=15
patien
tswho
dev
elop
edCKD
atbirthor
duringfirsty
ear
oflife;13
boys
and2girls;mean
follo
w-uppe
riod
,50mo
Prospective
coho
rtstud
yCT;E
EG;n
erve
cond
uction
velocity;A
BER
Allpa
tien
tsha
dano
rmal
neurologicexam
ination
apartfrom
hypo
tonia.
Five
hadmicrocepha
ly.
The
rewas
acorrelationbe
tweenmalnu
trition
inthefirst2ye
arsof
lifean
dmicroceph
aly.
Dev
elop
men
tald
elay
was
presen
tin3pa
tien
tswithmicrocepha
ly.B
rain
atroph
ywas
seen
inon
ly3of
13pa
tien
ts.E
EG
resu
ltswereab
norm
alin
6pa
tien
ts.O
nly1pa
tien
thad
dim
inishe
dne
rvecond
uctionve
locity;a
llpa
tien
tsha
da
norm
alABER.N
oneof
thepa
tien
tsdev
elop
edprog
ressiveen
cepha
lopa
thyor
recu
rren
tseizures.A
polic
yof
nooral
aluminum
therap
yan
dearlynu
tritiona
lsupp
ortleadsto
better
neurolog
icou
tcom
ein
child
renwithearlyCKD.
Clin J Am Soc Nephrol 8: 1429–1448, August, 2013 Neuroimaging in CKD, Moodalbail et al. 1441
Tab
le3.(Continued
)
Authors
SampleDescription
StudyDesign
Imag
ing
Techn
ique
Used
MainFind
ings
Pueshe
letal.(19
91)
n=3pa
tien
tswithLow
esynd
rome
Cross-section
alstud
yMRI
The
stud
yem
pha
sizedtheCNSan
drena
lpa
tholog
yof
Low
esynd
rome.MRIshow
eddiffuse
high
T2sign
alsin
thepe
rive
ntricu
lar
region
,ind
icatingsign
ificant
white
matter
destruction,
which
may
contribu
teto
the
intelle
ctua
ldisab
ility,seizu
redisorder,
hypo
tonia,
andarefl
exia
seen
inLow
e’ssynd
rome.
Cocha
tetal.(19
86)
n=10
patien
tswithcystinosis;
meanag
e,14
.2yr
n=10
compa
risoncaseswith
prim
aryrena
ldisease
butno
cerebral
abno
rmalities;
meanag
e,11
.8yr
Case-control
stud
yCT
Bothgrou
psinclud
eddialyzedch
ildrenor
tran
splant
recipien
tswitho
uts
ignificant
differenc
ein
leng
thof
ESR
Dman
agem
ent.
Cranial
CTsh
owed
brainatroph
yin
cystinotic
patien
tsch
aracterizedby
enlargem
ento
fcortical
sulciin80
%of
casesve
rsus
only
20%
from
thecompa
risongrou
p.
Steinb
ergetal.(19
85)
n=22
patien
tswithCKD
(6with
stab
leCKD,1
4on
dialysis,2
post-trans
plant);ag
erang
e,2–
18yr
Cross-section
alstud
yCT
Brain
atrophy
was
presen
tin13
patien
ts(59%
),pa
rticularly
forpa
tien
tsreceivingHD.T
wo
patien
tsha
dcortical
infarcts,a
nd1ha
da
hypo
den
searea
intheba
salg
anglia.M
etab
olic
deran
gemen
tsan
d/or
theaccu
mulationof
toxic
substanc
esdue
tourem
icstatemay
berelated
tobrainatrophy
inyo
ungpa
tien
tswithCKD.
Recurrent
osmoticch
ange
sof
thebrainduring
HD
may
contribu
teto
thepresen
ceof
brainatroph
y.Kretzschm
aretal.(19
83)
n=22
HD
patien
tsProspective
stud
yCT
Cranial
CTwas
performed
before
andafterHD
inallp
atientsan
din
halfof
thosepa
tien
ts8mo
later.In
halfof
cases,brainatrophy
was
reco
gnizab
le,w
ithdecreased
absorption
ofcerebral
parenc
hymaafterHD
in73
%of
the
cases.Thisfind
ingispa
rtly
explaine
dby
cerebral
edem
aor
hydration
.Schn
aper
etal.(19
83)
n=15
patien
tswithESR
D,n
one
withSL
E;5
boys
and10
girls;ag
erang
e,3.5–
20yr;d
ialysis(n=14
)an
d/or
rena
ltrans
plan
t(n=
13)
Prospective
stud
yCT
Corticala
trop
hywas
seen
in8casesan
dve
ntricu
laren
largem
entinan
additiona
l2.
Corticala
trop
hywas
notassociated
withclinical
sign
sor
symptom
s.The
meanleng
thof
timethe
patien
tsreceived
long
-term
HD
was
twiceas
long
inpa
tien
tswithatroph
y(30.8mo)
asin
thosewithno
rmal
scan
s(14.6mo).T
heleng
thof
timethat
patien
tsreceived
dialysis
contribu
tedto
thecortical
atroph
y.
1442 Clinical Journal of the American Society of Nephrology
Tab
le3.(Continued
)
Authors
SampleDescription
StudyDesign
Imag
ing
Techn
ique
Used
MainFind
ings
Dettorietal.(19
82)
n=48
patien
tswithESR
D;2
8bo
ysan
d35
girls;ag
erang
e,6–
71yr;
38receivingdialysis
n=15
patien
tswithCKD
Case-controlstudy
CT
Nomorpho
logicmod
ification
swereob
served
.Sign
ificant
chan
gesin
den
sity
weredem
onstrated
afteradialysissessionin
thepo
pulation
treated
interm
ittently.P
atientswithESR
Dwho
were
undergo
ingCAPD
alway
sha
dno
rmal
den
sity
values.C
ereb
rald
ensity
chan
gesrelatedon
lyto
interm
ittent
dialytictreatm
ent.
LaGreca
(198
2)n=
30pa
tien
tson
HD
orPD
;16
boys
and14
girls;ag
erang
e,10
–59
yrn=
10no
rmal
controls
Case-controlstudy
CT
CTof
thehe
adwas
cond
uctedbe
fore,immed
iately
after,an
d6hr
afterdialysis.Den
sity
did
not
decreasein
healthype
rson
sor
inpa
tien
tson
continuou
sPD
.The
absenc
eof
den
sity
variations
inCAPD
was
explaine
dby
agrad
ual
stab
ledeliveryof
fluid
columns
andsolutes.
Papag
eorgiouetal.(19
82)
n=25
patien
tswithESR
D;1
4bo
ysan
d11
girls;meanag
e,50
yrn=
45HD
patien
ts;2
1bo
ysan
d24
girls;meanag
e,46
yrn=
20he
althycontrols;1
0bo
ysan
d10
girls;meanag
e,55
yr
Case-controlstudy
CT
Non
eof
thepa
tien
tsha
dclinical
sign
sof
urem
icen
cepha
lopa
thy.
Ven
triclesweresign
ificantly
enlarged
inbo
thgrou
pscompa
redwiththe
controls,w
iththegreatest
enlargem
entinthe
patien
tsun
dergo
ingHD.V
entricular
enlargem
ente
xpresses
thedeg
reeof
brain
atrophy
,which
inESR
Dmay
bedue
tothe
metab
olic
factorsof
rena
ldisease
andin
HD
toalum
inum
toxicity.
Passer
(197
7)n=
33rena
lpatients;meanSC
r,11
.6mg/
dl;ag
erang
e,4–
72yr
Healthy
controlswereag
ematch
edto
rena
lgroup
and
rand
omly
selected
from
radiologicfiles
Case-controlstudy
CT
Patien
tsun
derwen
tCTas
partof
theirpred
ialysis
evaluation.
Normal
controlswerescan
nedfor
head
ache
sor
trau
maticinjury
tothehe
ad.
Cereb
rala
trop
hywas
presen
tinen
d-stage
urem
ia.D
egreeof
atroph
ycorrelated
with
theag
eat
onseto
fend
-stage
urem
iaan
dwas
mostm
arke
dduring
theyo
unge
rag
esof
cerebral
dev
elop
men
t.
CT,com
putedtomog
raphy
;MRI,mag
neticresona
nceim
aging;
EEG,electroen
ceph
alog
raphy
;ABERau
ditorybrainstem
evok
edresp
onse;C
NS,
centraln
ervo
ussystem
;HD,h
emod
ialysis;
SLE,systemic
lupu
serythe
matosus
;CAPD
,con
tinu
ousam
bulatory
peritone
aldialysis;PD
,periton
eald
ialysis;SC
r,serum
creatinine
.
Clin J Am Soc Nephrol 8: 1429–1448, August, 2013 Neuroimaging in CKD, Moodalbail et al. 1443
Table 4. Summary of common findings across the neuroimaging studies
Common Theme (Total n=43)CKD Populations Studied
Non-ESRD Dialysis Post-Transplant
Cerebral atrophy and cerebral density changesFazekas et al. (1995) [A] XSavazzi et al. (1999) [A] XYoshimutu et al. (2000) [A] XWalters et al. (2001) [A] XAǧildere et al. (2006) [A] XProhovnik et al. (2007) [A] XYakushiji (2010) [A] XPasser (1977) [P] XDettori et al. (1982) [P] X XLa Greca et al. (1982) [P] XPapageorgiou et al. (1982) [P] X XKretzschmar et al. (1983) [P] XSchnaper et al. (1983) [P] XSteinberg et al. (1985) [P] X X XCochat et al. (1986) [P] X XElzouiki et al. (1994) [P] X
Cerebral vascular abnormalitiesWhite matter lesions/abnormalitiesPueshel et al. (1991) [A] XAǧildere et al. (2006) [A] XMartinez-Vea et al. (2006) [A] XKhatri et al. (2007) [A] XKim et al. (2007) [A] XWatanabe et al. (2007) [A] XIkram et al. (2008) [A] XWada et al. (2008) [A] XShima et al. (2010) [A] XKim et al. (2011) [A] XNaganuma et al. (2011) [A] XNam et al. (2011) [A] X XTryc et al. (2011) [A] X XNaganuma et al. (2012) [A] XIshikura et al. (2006) [P] X X
Silent cerebral infarctionNakatani et al. (2003) [A] XKobayashi et al. (2009) [A] XKobayashi et al. (2010) [A] X
Cortical infarctsLass et al. (1999) [A] X X XQvist et al. (2002) [A] XKobayashi et al. (2004) [A] XValanne et al. (2004) [A] X
Effect of hemodialysis on cerebral circulation/oxygenationGottlieb et al. (1987) [A] XHata et al. (1994) [A] XMetry et al. (2002) [A] XSkinner et al. (2005) [A] XSteafnidis et al. (2005) [A] XProhovnik et al. (2007) [A] X
Depression and kidney diseaseKim t al. (2007) [A] XKim et al. (2008) [A] XNam et al. (2011) [A] X X
OtherIntracranial cystsSchievink et al. (1995) [A] X
A, adult study; P, pediatric study.
1444 Clinical Journal of the American Society of Nephrology
in adults with CKD. Lass et al. (37) documented discretecortical defects consistent with infarcts in 82% of their het-erogeneous patient sample (patients with CKD and thoseundergoing dialysis), with the defects being observable ineach of the lobules.Although magnetic resonance spectroscopy does not
assess rCBF, it provides indices that help elucidate neuro-chemical functions within the brain. To date one study hasassessed magnetic resonance spectroscopy in adults withCKD. Using magnetic resonance spectroscopy in HDpatients, patients with stage 4 and 5 CKD, and matchedhealthy controls, Tryc et al. (11) reported reduced brainactivity, as defined by targeted neurometabolites relatedto healthy brain functioning (i.e., choline, N-acetylaspartate,and N-acetylaspartylglutamate), in HD patients. Addition-ally, memory/learning and attention impairments were ob-served in both nondialyzed and dialyzed patients with CKD,but more severe cognitive dysfunction and neurometabolicalterations were seen in HD patients than in those withCKD stages 4 and 5.Finally, the relationship between CKD and depression in
adults also has received attention in the neuroimagingliterature. Kim et al. (14) demonstrated that in 27 patientswith CKD, rCBF patterns correlated with symptom clus-ters of depressive mood. These findings were similar tothose in individuals with major depressive disorder with-out CKD (38) and patients with Parkinson disease and de-pression (39). More recently, Nam et al. (10) studied 14patients with CKD before and 6 months after HD andfound correlations between reduced levels of depression,higher perfusion in the left middle temporal gyrus, andhigher rCBF in the right parahippocampal gyrus. Theselatter findings implicate the importance of the kidney-brain connection not only in the neurologic aspect of cog-nition and learning but also in the affective presentation ofmany individuals with CKD, particularly with respect tothe appearance of affective disorders.Table 2 summarizes the adult functional neuroimaging
studies in CKD.
Pediatric Neuroimaging StudiesThirteen studies included children with CKD in their
neuroimaging protocols. Unlike the adult studies, all of thepediatric studies to date have been of a structural nature.These studies span from 1977 (40) to 2006 (41). The studydesigns included retrospective, cross-sectional, case-control,and prospective approaches to data collection. Samplesizes ranged widely, with the composition of the CKDsamples reflecting significant heterogeneity across studies.For the structural neuroimaging studies, all of the pediat-ric investigations used CT, and several studies also usedMRI.
Findings in Pediatric Structural Neuroimaging StudiesAs with adults, cerebral atrophy has been noted in
children with ESRD, and this appears to be more prevalentin the HD population. Passer (40) was one of the first fewto publish neuroimaging findings in ESRD. Thirty-threepatients with ESRD secondary to various causes under-went head CT as part of their predialysis evaluation.This group of patients ranged widely in age and included
children. Cerebral atrophy was noted in ESRD, with thedegree of atrophy correlating with the age of onset. Similarfindings have been reported by other investigators (42–44)using solely pediatric samples; Qvist et al. (45) documentedthe presence of cerebral atrophy even after transplant in15% of their cases.Papageorgiou et al. (46) conducted a similar comparative
study of brain atrophy in patients with CKD and thoseundergoing long-term HD age 16–70 years comparedwith age-matched controls. None of the patients had clin-ical signs of uremic encephalopathy. Compared with theirage-matched controls, the renal patients had significantlyenlarged ventricles, with the greatest enlargement noted inthe HD group. Using a small sample of pediatric patientswho developed CKD at birth, Elzouki and colleagues (47)found that approximately 23% showed cerebral atrophy.Enlarged ventricles, a correlate of brain atrophy, have alsobeen reported by investigators studying primarily pediat-ric samples; estimates were significantly higher andranged from 59% (44) to 67% (43). In addition, enlargedcortical sulci have been reported on cranial CT in up to80% of pediatric cases with cystinosis (48). Widening ofcerebrospinal fluid spaces secondary to brain atrophy(42), with lower cerebral density, has been typically asso-ciated with HD (43,49) in comparison with patients receiv-ing continuous ambulatory PD (50). In general, theliterature suggested that although brain atrophy was evi-dent in patients with stable CKD and those receiving con-tinuous ambulatory PD, it was definitely more frequent inHD patients.In addition to cerebral atrophy, brain lesions have also
been documented using both CT and MRI. Specifically,Ishikura et al. (41) studied 20 cases of posterior reversibleencephalopathy syndrome. In most patients, radiologic ab-normalities extended to the gray matter (85%), particularlyin the frontal and temporal lobes, and the cerebellum.Moreover, ischemic lesions have been documented in thevascular border zones at a rate of about 54% in childrenwho received a renal transplant before 5 years of age(45,51). Cortical infarcts have been documented aftertransplant as well (44,45). These findings, however, alsoshowed the presence of various neurologic deficits (e.g.,brain infarcts, cerebral atrophy) and other factors (e.g.,history of hemodynamic crisis, prematurity, congenital ne-phrosis), including hypercoagulability related to long-termPD before transplantation, suggesting a priori brain insultsduring the first 5 years of life (51).Table 3 summarizes the pediatric structural neuroimag-
ing studies in CKD.
DiscussionThis review of the neuroimaging literature in CKD
provides a contemporary examination of one importantfacet of the kidney-brain connection: namely, structuraland functional neuroimaging studies in CKD. This reviewcomplements earlier reviews conducted on this topic but toour knowledge is the first to include both pediatric andadult studies and to focus on the structural and functionalfindings in the brain.This review focused on understanding potential linkages
between kidney disease and brain structural and functional
Clin J Am Soc Nephrol 8: 1429–1448, August, 2013 Neuroimaging in CKD, Moodalbail et al. 1445
integrity across the lifespan. As can be seen in Table 4,several clear findings emerged. In addition to clusteringstudies under four major themes, Table 4 shows the sam-ple composition for these studies. The three substantivethemes are presented below.
Cerebral Atrophy and Cerebral Density Changes Are Foundin Children and Adults With CKDBoth cerebral atrophy and cerebral density changes have
been noted in CKD, particularly with more severe kidneydisease. These findings were seen more frequently in bothchild and adult patients on intermittent dialysis treatments(long-term HD, intermittent PD) than in patients with CKD(who were not receiving dialysis) or patients undergoingcontinuous veno-venous hemofiltration (CVVH). Thesechanges were present in adults but were more markedduring the periods of cerebral development in children.These findings were not necessarily associated with thepresence of neurologic signs or symptoms, but up to 59% ofthese cases were noted to have brain atrophy (44). Recurrentosmotic changes of the brain during HD and aluminum tox-icity (in older studies) were associated with a greater risk forbrain atrophy in HD patients. The degree of brain atrophyalso has been related to predialytic BP and the duration ofhypertension. Even after transplantation, the prevalence ofcerebral atrophy is at least 15%–20%.Similarly, significant changes in cerebral density have
been discovered in both children and adults with CKD,with changes reported after HD but not after CVVH. Thesefindings favor continuous RRTs, such as CVVH, to avoidthis effect; however, this is not a viable treatment option forlong-term outpatient dialysis therapy. In general, thesefindings support the ongoing study of more frequent and/or intensive dialysis regimens, in place of HD three times aweek (52).
Signs of Cerebral Vascular Disease Are Seen in Children andAdults with CKDBoth kidney and brain are highly vascularized organs
and may share sensitivity to vascular disease. Accordingly,the brains of patients with CKD tend to show confluentdeep white matter hyperintensities, WMLs, cerebral micro-bleeds, and territorial cerebral infarcts. ESRD, chronologicage, and hypertension appear to be significant predictors ofthe presence of abnormal subcortical white matter. Thesefindings indicate how kidney disease and its sequelae leadto cerebrovascular disease through microangiopathy (23).Further, vascular nephropathy was found to be the mostimportant factor related to the presence of these lesions,suggesting that WMLs may reflect ischemic brain damagesecondary to generalized vascular damage. Conversely,stage and duration of CKD have not been linked to thepresence of WMLs.CKD has been related to small vessel disease–related
lesions. Lower eGFR levels and albuminuria were associ-ated with more lacunar infarcts and higher grades ofWMLs and less white matter volume. These findingswere present after adjustment for age, sex, and cardiovas-cular factors and when individuals with stage 2 hyperten-sion, cardiovascular risk factors, or diabetes were excludedfrom examination (23,25). Similarly, the incidence of
cerebral microbleeds appears to be high in patients receiv-ing maintenance HD, with rates hovering around 25%–
35% (31). These findings point to poor renal functionas a significant risk factor for cerebral microbleeds aswell as for future cerebrovascular events. It is interestingto know that although no relationship between anticoagu-lants and cerebral microbleeds has been uncovered inadults, this relationship has not been studied in pediatricpatients.Further evidence from these studies points to the pres-
ence of cerebral infarctions as being present in CKD, serv-ing as yet another marker of possible cerebrovasculardisease. The prevalence of silent cerebral infarctions hasbeen shown to be at least 50% in patients with ESRD (40).Among causes of CKD, hypertensive nephrosclerosishad a strong association with silent brain infarctions,and lower/declining eGFR, chronologic age, and hyper-tension were independently associated with a higher prev-alence of silent brain infarction. Taken together, theseneuroimaging findings point to CKD as an independentrisk factor for these infarctions and provide a strong link-age to the risk for cerebrovascular disease.Finally, in adults receiving HD, blood flow velocities in
the middle cerebral artery and the basilar artery immedi-ately before and after HD are significantly reduced afterdialysis treatment (32). Functional imaging techniques,such as transcranial Doppler ultrasonography, should beconsidered to monitor rapid changes in cerebral circula-tion during HD treatments. To date, no studies have in-vestigated blood flow velocities in children with CKD,although such studies may provide early clues for the laterappearance of cerebrovascular disease.
Functional Brain Imaging Techniques Show CirculatoryPatterns Consistent with Affective DisordersFor adults, the available neuroimaging studies suggest
that rCBF patterns in CKD are similar to those seen inpatients with major depressive disorder without CKD.Conversely, improvement in depressive symptoms hasbeen associated with higher perfusion in the left middletemporal gyrus and higher rCBF in the right parahippo-campal gyrus (10,14). To date, no such studies have beenconducted with children and adolescents with CKD.
SummaryThis comprehensive review has analyzed structural and
functional neuroimaging in adults and children withkidney disease. This review points to several key evidence-based findings supporting the ongoing study of the kidney-brain connection, with noteworthy findings indicating thepresence of cortical atrophy and other structural differencesin both children and adults with CKD, particularly withincreasing disease burden and the need for RRT, and whilecontrolling for other disease-related factors. The findingsalso provided evidence suggesting developmental continu-ity of cerebrovascular involvement in both children andadults with CKD. These latter studies point to cerebrovas-cular disease as one primary mechanism for the appearanceof abnormal brain structure, impaired brain functions, andperhaps increasing cognitive impairments across the life-span.
1446 Clinical Journal of the American Society of Nephrology
Despite the overarching nature of the available studies,it is important to note that our systematic review alsorevealed several limitations that moderate the strength ofthe findings. The corpus of studies spans approximately 35years, with 30 of the 43 studies involving adults. Thenumber of pediatric studies is increasing, but to date nopublished functional imaging studies have directly exam-ined brain function in children and adolescents with CKD.Further, many of the earlier pediatric studies actuallyinclude both adults and children in their samples, thusobscuring the effects of CKD in child brain structure andfunction. Study designs ranged widely but largely usedcross-sectional approaches to patient ascertainment; thisraises issues of how CKD, and its changing degree ofseverity, interacts with neurodevelopmental aspect of brainstructure and function over time. Additionally, very fewlongitudinal studies have been conducted with adults orchildren. Only a small subset of the included studiesfocused on functional neuroimaging. Finally, most of thestudies were conducted with small and/or heterogeneoussamples of individuals with CKD and RRT, although therewere some notable exceptions in the structural neuro-imaging literature for adults.In the future, it will be of interest to expand studies
to link complications of CKD, such as hypertension andbone mineral disorder, with neuroimaging. One such studyof interest is the ongoing, National Institutes of Health–sponsored SPRINT-MIND (Systolic Blood Pressure In-tervention Trial-Memory and Cognition in DecreasedHypertension) study, which will determine whether alower systolic BP goal will further reduce the risk of car-diovascular and kidney disease or age-related cognitivedecline. Future pediatric study designs should aim at re-cruiting pure CKD population (with no history of prema-turity, underlying central nervous system abnormalities,or genetic disorders) because that will permit study of thekidney-brain connection with perhaps more careful consid-eration. The use of neuroimaging procedures as part of rou-tine clinical care requires ongoing investigation, but thesefindings do point to the use of such procedures for casesshowing neurologic symptoms. Their use from a preventivestance for young patients with CKD also holds promise withrespect to managing their cerebrovascular health and asso-ciated neurologic morbidity across the lifespan.
AcknowledgmentsThis study was supported by the Pennsylvania Department of
Health: Commonwealth Universal Research Enhancement (CURE)Program, Health Research Formula Grant Award SFY 2010-14awarded to The Children’s Hospital of Philadelphia.
DisclosuresS.R.H. reported researchand travel support received fromEliLilly
and The Children’s Hospital of Philadelphia. The other authors hadno conflicts to report.
References1. Gerson AC, Butler R,Moxey-MimsM,Wentz A, Shinnar S, Lande
MB, Mendley SR, Warady BA, Furth SL, Hooper SR: Neuro-cognitive outcomes in children with chronic kidney disease:Current findings and contemporary endeavors.Ment Retard DevDisabil Res Rev 12: 208–215, 2006
2. Butler WE, Barker FGI 2nd, Crowell RM: Patients with polycystickidney disease would benefit from routine magnetic resonanceangiographic screening for intracerebral aneurysms: A decisionanalysis. Neurosurgery 38: 506–515, discussion 515–516, 1996
3. Burn DJ, Bates D: Neurology and the kidney. J Neurol NeurosurgPsychiatry 65: 810–821, 1998
4. A�gildere AM, Kurt A, Yıldırım T, Benli S, Altinors N: MRI ofneurologic complications in end-stage renal failure patients onhemodialysis: pictorial review. Eur Radiol 11: 1063–1069, 2001
5. Brouns R, De Deyn PP: Neurological complications in renalfailure: A review. Clin Neurol Neurosurg 107: 1–16, 2004
6. Lakadamyali H, Ergun T: MRI for acute neurologic complicationsin end-stage renal disease patients on hemodialysis.Diagn IntervRadiol 17: 112–117, 2011
7. Vogels SCM, Emmelot-Vonk MH, Verhaar HJJ, Koek HL: Theassociation of chronic kidney disease with brain lesions on MRIor CT: A systematic review. Maturitas 71: 331–336, 2012
8. Gottlieb D, Mildworf B, Rubinger D, Melamed E: The regionalcerebral blood flow in patients under chronic hemodialytictreatment. J Cereb Blood Flow Metab 7: 659–661, 1987
9. Kim HS, Park JW, Bai DS, Jeong JY, Hong JH, Son SM, Jang SH:Diffusion tensor imaging findings in neurologically asymptom-atic patients with end stage renal disease. NeuroRehabilitation29: 111–116, 2011
10. NamH-Y, Song SH, KimS-J, Kwak IS, Kim IJ, Lee SB, LeeDW,KimBS, Pak K, Kim Y-K, Yun HS: Effect of dialysis on cerebral bloodflow in depressive end-stage renal disease patients. Ann NuclMed 25: 165–171, 2011
11. Tryc AB, Alwan G, Bokemeyer M, Goldbecker A, Hecker H,Haubitz M, Weissenborn K: Cerebral metabolic alterations andcognitive dysfunction in chronic kidney disease. Nephrol DialTransplant 26: 2635–2641, 2011
12. Ronco C, Bellomo R, Brendolan A, Pinna V, La Greca G: Braindensity changes during renal replacement in critically ill patientswith acute renal failure. Continuous hemofiltration versus in-termittent hemodialysis. J Nephrol 12: 173–178, 1999
13. Schievink WI, Huston J 3rd, Torres VE, Marsh WR: Intracranialcysts in autosomal dominant polycystic kidney disease. J Neu-rosurg 83: 1004–1007, 1995
14. Kim S-J, Song SH, Kim JH, Kwak IS: Statistical parametric map-ping analysis of the relationship between regional cerebral bloodflow and symptom clusters of the depressive mood in patientswith pre-dialytic chronic kidney disease. Ann Nucl Med 22:201–206, 2008
15. Watanabe A: Cerebral microbleeds and intracerebral hemor-rhages in patients on maintenance hemodialysis. J Stroke Cere-brovasc Dis 16: 30–33, 2007
16. Aǧıldere AM, Basxaran C, Cakır B, Ozgul E, Kural F, Haberal M:Evaluation of neurologic complications by brain MRI in kidneyand liver transplant recipients. Transplant Proc 38: 611–618,2006
17. Nakatani T, Naganuma T,Uchida J,Masuda C,Wada S, SugimuraT, Sugimura K: Silent cerebral infarction in hemodialysis patients.Am J Nephrol 23: 86–90, 2003
18. Walters RJL, Fox NC, Crum WR, Taube D, Thomas DJ: Haemo-dialysis and cerebral oedema. Nephron 87: 143–147, 2001
19. Yoshimitsu T, HirakataH, Fujii K, Kanai H, Hirakata E, Higashi H,KuboM, Tanaka H, Shinozaki M, Katafuchi R, Yokomizo Y, Oh Y,Tomooka S, Fujimi S, Fujishima M: Cerebral ischemia as acausative mechanism for rapid progression of brain atrophy inchronic hemodialysis patients. Clin Nephrol 53: 445–451, 2000
20. Savazzi GM, Cusmano F, Bergamaschi E, Vinci S, Allegri L,Garini G: Hypertension as an etiopathological factor in the de-velopment of cerebral atrophy in hemodialyzed patients.Nephron 81: 17–24, 1999
21. Fazekas G, Fazekas F, Schmidt R, Kapeller P, Offenbacher H,Krejs GJ: BrainMRI findings and cognitive impairment in patientsundergoing chronic hemodialysis treatment. J Neurol Sci 134:83–88, 1995
22. Martinez-Vea A, Salvado E, Bardajı A, Gutierrez C, Ramos A,Garcıa C, Compte T, Peralta C, Broch M, Pastor R, Angelet P,Marcas L, Saurı A, Oliver JA: Silent cerebral white matter lesionsand their relationship with vascular risk factors in middle-agedpredialysis patients with CKD. Am J Kidney Dis 47: 241–250,2006
Clin J Am Soc Nephrol 8: 1429–1448, August, 2013 Neuroimaging in CKD, Moodalbail et al. 1447
23. Wada M, Nagasawa H, Iseki C, Takahashi Y, Sato H, Arawaka S,Kawanami T, Kurita K, Daimon M, Kato T: Cerebral small vesseldisease and chronic kidney disease (CKD): Results of a cross-sectional study in community-based Japanese elderly. J NeurolSci 272: 36–42, 2008
24. Khatri M, Wright CB, Nickolas TL, Yoshita M, Paik MC,Kranwinkel G, Sacco RL, DeCarli C: Chronic kidney diseaseis associated with white matter hyperintensity volume: TheNorthern Manhattan Study (NOMAS). Stroke 38: 3121–3126,2007
25. IkramMA, Vernooij MW,Hofman A, NiessenWJ, van der Lugt A,Breteler MMB: Kidney function is related to cerebral small vesseldisease. Stroke 39: 55–61, 2008
26. Yakushiji Y, Nanri Y, Hirotsu T, NishiharaM, HaraM, Nakajima J,Eriguchi M, Nishiyama M, Hara H, Node K: Marked cerebralatrophy is correlated with kidney dysfunction in nondisabledadults. Hypertens Res 33: 1232–1237, 2010
27. NaganumaT, Takemoto Y, Shoji T, ShimaH, Ishimura E,OkamuraM, Nakatani T: Factors associated with cerebral white matterhyperintensities in haemodialysis patients.Nephrology (Carlton)17: 561–568, 2012
28. Kobayashi S, Ikeda T, Moriya H, Ohtake T, Kumagai H: Asymp-tomatic cerebral lacunae in patientswith chronic kidney disease.Am J Kidney Dis 44: 35–41, 2004
29. KobayashiM, HirawaN, Yatsu K, Kobayashi Y, Yamamoto Y, SakaS, Andoh D, Toya Y, Yasuda G, Umemura S: Relationship be-tween silent brain infarction and chronic kidney disease.Nephrol Dial Transplant 24: 201–207, 2009
30. Shima H, Ishimura E, Naganuma T, Yamazaki T, Kobayashi I,Shidara K, Mori K, Takemoto Y, Shoji T, Inaba M, Okamura M,Nakatani T, Nishizawa Y: Cerebral microbleeds in predialysispatients with chronic kidney disease. Nephrol Dial Transplant25: 1554–1559, 2010
31. Naganuma T, Takemoto Y, Yamasaki T, ShimaH, Shoji T, IshimuraE, Nishizawa Y, Morino M, Okamura M, Nakatani T: Factors as-sociated with silent cerebral microbleeds in hemodialysis pa-tients. Clin Nephrol 75: 346–355, 2011
32. Prohovnik I, Post J, Uribarri J, Lee H, Sandu O, Langhoff E: Ce-rebrovascular effects of hemodialysis in chronic kidney disease.J Cereb Blood Flow Metab 27: 1861–1869, 2007
33. Skinner H, Mackaness C, Bedforth N, Mahajan R: Cerebralhaemodynamics in patients with chronic renal failure: Effects ofhaemodialysis. Br J Anaesth 94: 203–205, 2005
34. Stefanidis I, BachR,Mertens PR, Liakopoulos V, LiapiG,MannH,Heintz B: Influence of hemodialysis on the mean blood flowvelocity in themiddle cerebral artery.Clin Nephrol 64: 129–137,2005
35. Hata R, Matsumoto M, Handa N, Terakawa H, Sugitani Y,Kamada T: Effects of hemodialysis on cerebral circulation eval-uated by transcranial Doppler ultrasonography. Stroke 25: 408–412, 1994
36. Metry G, Spittle M, Rahmati S, Giller C, Giller A, Kaufman A,Schneditz D, Manno E, Brener Z, Boniece I, Ronco F, Ronco C,Levin NW: Online monitoring of cerebral hemodynamics duringhemodialysis. Am J Kidney Dis 40: 996–1004, 2002
37. Lass P, Buscombe JR, Harber M, Davenport A, Hilson AJ: Cog-nitive impairment in patients with renal failure is associated
with multiple-infarct dementia. Clin Nucl Med 24: 561–565,1999
38. Bench CJ, Friston KJ, Brown RG, Frackowiak RS, Dolan RJ: Re-gional cerebral blood flow in depression measured by positronemission tomography: The relationship with clinical dimensions.Psychol Med 23: 579–590, 1993
39. Wu H, Lou C, Huang Z, Shi G: SPECT imaging of dopaminetransporters with (99m)Tc-TRODAT-1 in major depression andParkinson’s disease. J Neuropsychiatry Clin Neurosci 23: 63–67,2011
40. Passer JA: Cerebral atrophy in end-stage uremia. Proc Clin DialTransplant Forum 7: 91–94, 1977
41. Ishikura K, IkedaM,Hamasaki Y, HatayaH, Shishido S, AsanumaH, Nishimura G, Hiramoto R, Honda M: Posterior reversibleencephalopathy syndrome in children: Its high prevalence andmore extensive imaging findings. Am J Kidney Dis 48: 231–238,2006
42. Kretzschmar K, Nix W, Zschiedrich H, Philipp T: Morphologiccerebral changes in patients undergoing dialysis for renal failure.AJNR Am J Neuroradiol 4: 439–441, 1983
43. Schnaper HW, Cole BR, Hodges FJ, Robson AM: Cerebral corticalatrophy in pediatric patients with end-stage renal disease. Am JKidney Dis 2: 645–650, 1983
44. Steinberg A, Efrat R, Pomeranz A, Drukker A: Computerizedtomography of the brain in children with chronic renal failure. Int JPediatr Nephrol 6: 121–126, 1985
45. Qvist E, Pihko H, Fagerudd P, Valanne L, Lamminranta S,Karikoski J, Sainio K, Ronnholm K, Jalanko H, Holmberg C:Neurodevelopmental outcome in high-risk patients after renaltransplantation in early childhood. Pediatr Transplant 6: 53–62,2002
46. Papageorgiou C, Ziroyannis P, Vathylakis J, Grigoriadis A,Hatzikonstantinou V, Capsalakis Z: A comparative study of brainatrophy by computerized tomography in chronic renal failureand chronic hemodialysis. Acta Neurol Scand 66: 378–385,1982
47. Elzouki A, Carroll J, Butinar D, Moosa A: Improved neurologicaloutcome in children with chronic renal disease from infancy.Pediatr Nephrol 8: 205–210, 1994
48. Cochat P, Drachman R, Gagnadoux M-F, Pariente D, Broyer M:Cerebral atrophy and nephropathic cystinosis.ArchDis Child 61:401–403, 1986
49. Dettori P, La Greca G, Biasioli S, Chiaramonte S, Fabris A, FerianiM, Pinna V, Pisani E, Ronco C: Changes of cerebral density indialyzed patients. Neuroradiology 23: 95–99, 1982
50. La Greca G, Biasioli S, Chiaramonte S, Dettori P, Fabris A, FerianiM, Pinna V, Pisani E, Ronco C: Studies on brain density in he-modialysis and peritoneal dialysis. Nephron 31: 146–150, 1982
51. Valanne L, Qvist E, Jalanko H, Holmberg C, Pihko H: Neuro-radiologic findings in children with renal transplantation under 5years of age. Pediatr Transplant 8: 44–51, 2004
52. Fischbach M, Fothergill H, Zaloszyc A, Menouer S, Terzic J: In-tensified daily dialysis: the best chronic dialysis option for chil-dren? Semin Dial 24: 640–644, 2011
Published online ahead of print. Publication date available at www.cjasn.org.
1448 Clinical Journal of the American Society of Nephrology